. "Suxamethonium"@en . "Humans and other mammals"@en . "Succinylcholine"@en . . . . "approved"@en . . . "# Jonsson M, Dabrowski M, Gurley DA, Larsson O, Johnson EC, Fredholm BB, Eriksson LI: Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology. 2006 Apr;104(4):724-33. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16571968"@en . "The mechanism of action of Succinylcholine involves what appears to be a \"persistent\" depolarization of the neuromuscular junction. This depolarization is caused by Succinylcholine mimicking the effect of acetylcholine but without being rapidly hydrolysed by acetylcholinesterase. This depolarization leads to desensitization."@en . . . "Succinic acid, diester with choline"@en . "Succinylcholine"@en . " "@en . . . . "2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)"@en . "Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT)"@en . "A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]"@en . . "306-40-1"@en . . . " "@en . . . . . . . "Dicholine succinate"@en . . . "Succinoylcholine"@en . . . . . . . . . . . . . . . . . . . . . "Walter Raml, Gunther Eichberger, \"Process for the preparation of succinylcholine halides.\" U.S. Patent US5206420, issued April 27, 1993."@en . "Succinylbischoline"@en . . . . "About 10% of the drug is excreted unchanged in the urine."@en . . . . . . . . . "Succinocholine"@en . . . "Succinyldicholine"@en . . . .